Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can the presence of micrometastases in patients with colorectal cancer be used to help guide treatment?

Nature Clinical Practice Gastroenterology & Hepatology volume 5, pages 244–245 (2008)Cite this article

boxed-textBilchik AJ et al. (2007) Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 246: 568–577

Minimal residual disease in the sentinel lymph nodes of patients with resectable colon cancer might have prognostic value in terms of disease recurrence if it is identified by molecular markers; however, further large-scale studies are needed

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bembenek A et al. (2004) Sentinel lymph node biopsy in rectal cancer—not yet ready for routine clinical use. Surgery 135: 498–505

    Article  CAS  Google Scholar 

  2. Iddings D et al. (2006) The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 13: 1386–1392

    Article  Google Scholar 

  3. Gray RG et al. (2004) A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients [abstract]. J Clin Oncol 22: s3501

    Article  Google Scholar 

  4. Benson AB 3rd et al. (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22: 3408–3419

    Article  Google Scholar 

  5. Resnick MB et al. (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18: 511–518

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. A Bembenek is a Consultant and PM Schlag is Head of the Department of Surgery and Surgical Oncology at the Charité University Hospital, Berlin, Germany.,

    Andreas Bembenek & Peter M Schlag

Authors
  1. Andreas Bembenek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter M Schlag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Bembenek.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bembenek, A., Schlag, P. Can the presence of micrometastases in patients with colorectal cancer be used to help guide treatment?. Nat Rev Gastroenterol Hepatol 5, 244–245 (2008). https://doi.org/10.1038/ncpgasthep1100

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep1100

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing